Stevens Capital Management LP Purchases New Holdings in Colgate-Palmolive Company $CL

22 Feb 2026, 12:48 by Tristan Rich · The Markets Daily

Stevens Capital Management LP bought a new position in shares of Colgate-Palmolive Company (NYSE:CL – Free Report) in the 3rd quarter, according to its most recent 13F filing with the SEC. The fund bought 9,864 shares of the company’s stock, valued at approximately $789,000.

Other large investors have also recently bought and sold shares of the company. Tiemann Investment Advisors LLC raised its stake in Colgate-Palmolive by 2.1% in the 2nd quarter. Tiemann Investment Advisors LLC now owns 6,083 shares of the company’s stock worth $553,000 after purchasing an additional 125 shares in the last quarter. Westside Investment Management Inc. grew its position in shares of Colgate-Palmolive by 85.5% in the 2nd quarter. Westside Investment Management Inc. now owns 282 shares of the company’s stock valued at $26,000 after buying an additional 130 shares during the last quarter. S.A. Mason LLC increased its position in shares of Colgate-Palmolive by 3.9% during the third quarter. S.A. Mason LLC now owns 3,499 shares of the company’s stock worth $280,000 after buying an additional 130 shares during the period. Security National Bank of Sioux City Iowa IA grew its holdings in Colgate-Palmolive by 0.8% in the third quarter. Security National Bank of Sioux City Iowa IA now owns 16,241 shares of the company’s stock worth $1,298,000 after purchasing an additional 130 shares during the period. Finally, Stratos Wealth Advisors LLC lifted its holdings in shares of Colgate-Palmolive by 4.5% in the 3rd quarter. Stratos Wealth Advisors LLC now owns 3,015 shares of the company’s stock worth $241,000 after purchasing an additional 130 shares in the last quarter. 80.41% of the stock is owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other news, insider John Hazlin sold 20,989 shares of the stock in a transaction dated Tuesday, February 10th. The shares were sold at an average price of $94.25, for a total value of $1,978,213.25. Following the completion of the transaction, the insider owned 17,645 shares in the company, valued at $1,663,041.25. This trade represents a 54.33% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, insider Sally Massey sold 15,851 shares of Colgate-Palmolive stock in a transaction that occurred on Thursday, February 5th. The stock was sold at an average price of $95.03, for a total transaction of $1,506,320.53. Following the completion of the sale, the insider directly owned 13,751 shares of the company’s stock, valued at $1,306,757.53. The trade was a 53.55% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 184,683 shares of company stock valued at $17,486,693 over the last 90 days. 0.34% of the stock is owned by corporate insiders.

Colgate-Palmolive Stock Up 1.2%

CL stock opened at $95.07 on Friday. The firm has a 50-day moving average of $85.61 and a two-hundred day moving average of $82.27. Colgate-Palmolive Company has a 12 month low of $74.54 and a 12 month high of $100.18. The company has a current ratio of 0.42, a quick ratio of 0.27 and a debt-to-equity ratio of 5.90. The company has a market cap of $76.63 billion, a price-to-earnings ratio of 36.29, a PEG ratio of 4.29 and a beta of 0.29.

Colgate-Palmolive (NYSE:CL – Get Free Report) last released its earnings results on Friday, January 30th. The company reported $0.95 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.91 by $0.04. Colgate-Palmolive had a return on equity of 353.72% and a net margin of 10.45%.The firm had revenue of $5.23 billion during the quarter, compared to analyst estimates of $5.13 billion. During the same period last year, the business posted $0.91 earnings per share. Colgate-Palmolive’s revenue was up 5.8% compared to the same quarter last year. As a group, analysts forecast that Colgate-Palmolive Company will post 3.75 earnings per share for the current fiscal year.

Colgate-Palmolive Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Friday, February 13th. Stockholders of record on Wednesday, January 21st were paid a dividend of $0.52 per share. This represents a $2.08 dividend on an annualized basis and a dividend yield of 2.2%. The ex-dividend date of this dividend was Wednesday, January 21st. Colgate-Palmolive’s dividend payout ratio is 79.39%.

Wall Street Analysts Forecast Growth

A number of research firms have issued reports on CL. Rothschild & Co Redburn set a $93.00 price objective on shares of Colgate-Palmolive in a report on Friday, February 13th. Royal Bank Of Canada upgraded Colgate-Palmolive from a “sector perform” rating to an “outperform” rating and set a $88.00 target price on the stock in a research note on Tuesday, December 9th. Citigroup increased their target price on shares of Colgate-Palmolive from $95.00 to $105.00 and gave the stock a “buy” rating in a report on Monday, February 2nd. Wells Fargo & Company upped their target price on shares of Colgate-Palmolive from $86.00 to $94.00 and gave the stock an “equal weight” rating in a research report on Sunday, February 1st. Finally, TD Cowen reaffirmed a “buy” rating on shares of Colgate-Palmolive in a report on Monday, February 2nd. Eleven equities research analysts have rated the stock with a Buy rating and six have given a Hold rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $94.75.

Read Our Latest Stock Analysis on Colgate-Palmolive

About Colgate-Palmolive

(Free Report)

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.